Shares of Qualigen Therapeutics, Inc. (NASDAQ:QLGN – Get Free Report) were down 5.2% during trading on Thursday . The company traded as low as $4.15 and last traded at $4.17. Approximately 18,089 shares traded hands during mid-day trading, a decline of 22% from the average daily volume of 23,158 shares. The stock had previously closed at $4.40.
Qualigen Therapeutics Stock Up 2.6 %
The business has a 50 day moving average of $4.30 and a 200 day moving average of $7.81.
About Qualigen Therapeutics
Qualigen Therapeutics, Inc, a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a patent-protected rapid, onsite immunoassay testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide-based drug candidate to treat various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases, such as COVID-19; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device to remove circulating tumor cells, viruses, inflammation factors, and immune checkpoints.
Featured Stories
- Five stocks we like better than Qualigen Therapeutics
- What Are Treasury Bonds?
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- 3 Tickers Leading a Meme Stock Revival
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Bank Stocks – Best Bank Stocks to Invest In
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Qualigen Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qualigen Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
